Briaud Financial Planning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$460K Sell
1,270
-36
-3% -$12.3K 0.12% 26
2026
Q1
$460K Sell
1,306
-14
-1% -$4.99K 0.12% 24
2025
Q4
$432K Buy
1,320
+505
+62% +$160K 0.11% 23
2025
Q3
$230K Hold
815
0.08% 31
2025
Q2
$227K Buy
815
+209
+34% +$59.2K 0.09% 30
2025
Q1
$188K Buy
606
+506
+506% +$149K 0.07% 35
2024
Q4
$26K Hold
100
0.01% 108
2024
Q3
$32K Hold
100
0.02% 79
2024
Q2
$31K Hold
100
0.02% 76
2024
Q1
$29K Buy
+100
New +$29.3K 0.02% 73
2023
Q4
Sell
-100
Closed -$26K 18
2023
Q3
$26K Buy
+100
New +$25K 0.02% 77

Other funds holding AMGN

Briaud Financial Planning's AMGN Position: Q2 2026 in Review

Briaud Financial Planning reduced its Amgen (AMGN) stake by 2.8% in Q2 2026, selling an estimated $12.3K and leaving 1,270 shares worth $460K. The position accounts for 0.12% of the portfolio, ranked #26.

Briaud Financial Planning first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Briaud Financial Planning held 1,270 shares of Amgen worth $460K as of Q2 2026.
  • Briaud Financial Planning sold 36 Amgen shares in Q2 2026, an estimated $12.3K.
  • Amgen made up 0.12% of Briaud Financial Planning's portfolio in Q2 2026, its #26 holding.
  • Briaud Financial Planning first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Briaud Financial Planning's 13F filing for Q2 2026, filed 30 Jul 2026.